financetom
Business
financetom
/
Business
/
Road building equipment maker Astec's Q2 sales miss estimates, adjusted EPS beats
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Road building equipment maker Astec's Q2 sales miss estimates, adjusted EPS beats
Aug 6, 2025 4:53 AM

Overview

* Astec Q2 net sales fall 4.4% yr/yr, missing analyst expectations

* Adjusted EPS for Q2 beats consensus, reflecting improved operational efficiency

* Co completes acquisition of TerraSource, expected to boost future earnings

Outlook

* Astec updates full-year adjusted EBITDA guidance to $123 mln-$142 mln

* Company expects TerraSource to contribute $13 mln-$17 mln in H2 adjusted EBITDA

Result Drivers

* INFRASTRUCTURE CHALLENGES - Net sales in Infrastructure Solutions fell 7.6% due to weak demand for mobile paving and forestry equipment

* OPERATIONAL EFFICIENCIES - Co attributes growth in adjusted EBITDA and EPS to enhanced manufacturing and procurement efficiencies

* TERRASOURCE ACQUISITION - Acquisition completed, expected to boost earnings with strong aftermarket parts revenue

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Miss $330.30 $354.20

mln mln (2

Analysts

)

Q2 Beat $0.88 $0.56 (2

Adjusted Analysts

EPS )

Q2 $29 mln

Adjusted

EBITDA

Q2 8.8%

Adjusted

EBITDA

Margin

Q2 7.9%

Adjusted

Operatin

g margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the heavy machinery & vehicles peer group is "buy"

* Wall Street's median 12-month price target for Astec Industries Inc ( ASTE ) is $43.00, about 6.1% above its August 5 closing price of $40.39

* The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mission Produce Fiscal Q3 Adjusted Earnings, Sales Rise -- Shares Soar After Hours
Mission Produce Fiscal Q3 Adjusted Earnings, Sales Rise -- Shares Soar After Hours
Sep 10, 2024
04:38 PM EDT, 09/09/2024 (MT Newswires) -- Mission Produce ( AVO ) reported fiscal Q3 adjusted net income late Monday of $0.23 per diluted share, up from $0.15 a year earlier. Two analysts surveyed by Capital IQ expected EPS of $0.03 normalized. Sales for the quarter ended July 31 were $324 million, compared with $261.4 million a year earlier. Two...
Limoneira Fiscal Q3 Adjusted Earnings, Revenue Rise -- Shares Up After Hours
Limoneira Fiscal Q3 Adjusted Earnings, Revenue Rise -- Shares Up After Hours
Sep 10, 2024
04:41 PM EDT, 09/09/2024 (MT Newswires) -- Limoneira ( LMNR ) reported late Monday fiscal Q3 adjusted net income of $0.42 per diluted share, up from $0.02 a year earlier. Two analysts polled by Capital IQ expected $0.34. Revenue for the quarter ended July 31 also climbed to $63.3 million from $52.5 million a year earlier. Three analysts expected $63.6...
Terns Pharmaceuticals Launching Share Offering
Terns Pharmaceuticals Launching Share Offering
Sep 10, 2024
04:45 PM EDT, 09/09/2024 (MT Newswires) -- Terns Pharmaceuticals ( TERN ) said Monday it has started a proposed underwritten public offering of $125 million of shares and pre-funded warrants to buy shares. The company said it expects to give its underwriters, including Jefferies and TD Cowen, a 30-day option to buy up to an additional $18.75 million of shares....
Rubrik Q2 Loss Narrows, Revenue Up; Issues Guidance
Rubrik Q2 Loss Narrows, Revenue Up; Issues Guidance
Sep 10, 2024
04:26 PM EDT, 09/09/2024 (MT Newswires) -- Rubrik ( RBRK ) late Monday reported a Q2 non-GAAP net loss of $0.40 per diluted share, compared with a $1.33 loss a year ago. Analysts polled by Capital IQ expected a $0.49 loss. Revenue for the quarter ended July 31 was $204.95 million, compared with $151.54 million a year earlier. Analysts expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved